Global Cancer Biomarker Market to Reach USD 33.7 Bn by 2022, Predicts Grand View Research in Its Topical Study Available at MarketPublishers.com

05 Jul 2017 • by Natalie Aster

LONDON – By 2022, the world’s cancer biomarkers market is expected to follow an upward trend to climb to USD 33.7 billion, encouraged by factors like the adoption of innovative diagnostic kits, increasing number of favourable initiatives and policies for the development of drugs associated with new cancer biomarkers, escalating awareness about the personalised medicine, strong government support and increasing investments into the development of new diagnostics techniques. Moreover, the expanding prevalence of such infections as Human papillomavirus (HPV) and Hepatitis B virus, among others, also spurs the global cancer biomarker marketplace.

As of 2016, breast cancer held the lion’s revenue share of the overall cancer biomarker market, primarily due to the rising incidence of this type of cancer. Meanwhile, propelled by the rising R&D activities towards the development of new biomarkers, the lung cancer sector is likely to grow at the fastest pace in the offing.

Regionally, the marketplace was dominated by North America in 2016 owing to the well-developed R&D infrastructure and constantly rising adoption of biomarker-based cancer testing in the region. Through 2025, APAC is likely to enjoy the highest growth rates (almost a 17% CAGR).

The new topical report “Cancer Biomarker Market Analysis By Type, By Biomolecule, By Application, And Segment Forecasts, 2014 - 2025” by Grand View Research is a trustworthy source of information on the current situation in the world’s market for cancer biomarkers. The report also includes historical statistics and market performance estimates as well as presents detailed future forecasts for the market up till 2025.

This comprehensive research publication comprises a detailed market segmentation analysis, highlights the market dynamics and reviews the major market growth drivers, hinders and challenges. It outlines the possible future development trends and opportunities of the cancer biomarker market, and discusses the burning market issues. Besides, the competitive scenario and top market participants are also covered in this report. Additionally, the report offers SWOT analysis.

Many other cutting-edge topical reports by Grand View Research are available in the publisher's catalogue at MarketPublishers.com.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com